ProCE Banner Events

Share

Enhancing the Use of GLP-1 RAs in Patients With T2D to Improve Individualized Patient-Centered Care - 9/28 webinar

Join us for a live webinar on the use of GLP-1 Receptor Agonists for the treatment of type 2 diabetes. Leading experts will discuss the glycemic and extra glycemic benefits of GLP-1 Receptor Agonists and how to tailor them to optimize the care of your patients.

This event has expired. No longer available for credits.

Who Should Attend

The target audience for this program is pharmacists, including clinical, community, ambulatory care, and health-system pharmacists, who care for patients with type 2 diabetes, as well as pharmacy directors, chief pharmacy officers, and other stakeholders in pharmacy practice.

Time and location

Wednesday, September 28, 2022

12:15 PM - 1:15 PM Central Time (CT)

Virtual

Agenda

Overview of GLP-1 Ras

Comparison of Available GLP-1 Ras

Individualizing GLP-1 RA Treatment

Strategies to Improve Patient Acceptance, Tolerance, and Adherence

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge and competence of pharmacists regarding the physiologic actions and optimal use of GLP-1 RAs in patients with T2D.

Accreditation

CE Accreditation

 

Pharmacists

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-206-L01-P has been assigned to this live application-based activity (initial release date 9-28-22). This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation within 30 days of the activity to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

 

Disclosure
ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. Faculty disclosures will be provided prior to the start of the CE activity.

Acknowledgement

Supported by an educational grant from Novo Nordisk.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191